Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related
The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
50 Biggest Movers From Yesterday
Related LVLT
Wall Street's M&A Chatter From October 30: Sprint-T-Mobile, Lennar-CalAtlantic, CenturyLink-Level 3, Dunkin Brands
Telecom Stock Roundup: T-Mobile, Sprint, CenturyLink And More

 

  • Credit Suisse initiated coverage of Allergan plc (NYSE: AGN) with a Outperform rating. The price target for Allergan is set to $327. Allergan shares rose 1.09 percent to $251.70 in pre-market trading.
  • Analysts at Piper Jaffray initiated coverage of Syros Pharmaceuticals Inc (NASDAQ: SYRS) with a Overweight rating. Syros Pharmaceuticals shares rose 4.80 percent to $12.00 in pre-market trading.
  • Pacific Crest initiated coverage on Level 3 Communications, Inc. (NYSE: LVLT) with a Sector Weight rating. Level 3 Communications shares rose 0.94 percent to close at $56.90 on Thursday.
  • Analysts at Morgan Stanley assumed VMware, Inc. (NYSE: VMW) with a Overweight rating. The price target for VMware is set to $86. VMware shares gained 0.70 percent to $72.05 in pre-market trading.
  • Analysts at Oppenheimer initiated coverage on Global Medical REIT Inc (NYSE: GMRE) with a Outperform rating. The price target for Global Medical REIT is set to $12. Global Medical REIT shares rose 2 percent to close at $10.73 on Thursday.
  • Analysts at Bank of America initiated coverage on Casey's General Stores Inc (NASDAQ: CASY) with a Buy rating. Casey's shares gained 0.59 percent to $134.30 in pre-market trading.
  • Analysts at FBR Capital initiated coverage on Aemetis Inc (NASDAQ: AMTX) with a Market Perform rating. Aemetis shares dropped 0.50 percent to close at $1.99 on Thursday.
  • Analysts at Cowen & Co. initiated coverage on Syros Pharmaceuticals Inc (NASDAQ: SYRS) with a Outperform rating. Syros Pharmaceuticals shares gained 4.80 percent to $12.00 in pre-market trading.

Latest Ratings for SYRS

DateFirmActionFromTo
Mar 2018WedbushMaintainsOutperformOutperform
Oct 2017PiperJaffrayAssumesOverweightOverweight
Sep 2017JMP SecuritiesUpgradesMarket PerformMarket Outperform

View More Analyst Ratings for SYRS
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AGN + AMTX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
FOLDCitigroupUpgrades0.0
EMNMorgan StanleyUpgrades90.0
DERMRaymond JamesUpgrades0.0
ARMKBerenbergUpgrades0.0
PENNNomuraUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

3 Reasons Credit Suisse Upgraded Alaska Air

Remember When Yahoo Turned Down $1 Million To Buy Google?